Herophilus Announces Strategic Transaction with Genentech for Next Generation Drug Discovery Platform
11 September 2023
BUSINESSWIRE
Read More
We think of Herophilus as the philosophical forebearer of our company’s approach. Herophilus was an Alexandrian physician (circa 300 BC) who pioneered the use of what we now call biophenotyping. He was the first to study the tissue and organs of cadavers to understand the etiology of disease. He was also the first to identify that nerves were distinct from blood vessels and tendons. As such, Herophilus was arguably the first neuroscientist as he was the first to prove that the brain, not the heart, was the seat of the intellect, revising the predominant view that held for two millennia since ancient Egypt.